-
Notable Analyst Rating Changes 05/22: (FB) (BAH) (NBR) Upgraded; (MT) (AEO) (SODA) Downgraded
-
Notable Analyst Rating Changes 02/19: (FLR) (ACT) (CPST) Upgraded; (YOKU) (SCTY) (NPSP) Downgraded
-
Pre-Open Movers 10/17: (CYMI) (PPHM) (CREE) Higher; (FTNT) (APOL) (STJ) Lower (more...)
-
Pre-Open Movers 9/19: (ACHN) (DCTH) (RMTR) Higher; (IDIX) (BONT) (LRCX) Lower (more...)
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Unusual 11 Mid-Day Movers 01/31: DEPO, SSN, DBLE, NPSP, ASIA, LNG Higher; IPCI, BGP, TGA, CHKE, REDF Lower
-
Citi 2010 Healthcare Conference Key Takeaways - MRK, PFE, BMY, ISIS, NPSP, & MYGN
-
Notable Analyst Rating Changes 6/11: RF, FITB, BBT, HBAN, STI, BAC, GSK Upgraded; UNH, TIN, ALV, VPRT Downgraded
-
Citi Reiterates a 'Buy' Rating on NPS Pharmaceuticals (NPSP) After Investor Meeting
-
Citi Initiates Coverage on NPS Pharmaceuticals (NPSP) with a Buy

